Krensavage Asset Management, LLC Taro Pharmaceutical Industries LTD Transaction History

Krensavage Asset Management, LLC

$178 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.0 - $42.97 $0 - $95,436	2,221 Added 0.34%	650,089 $28 Million
Q1 2024 May 15, 2024	BUY	$40.97 - $43.33 $57,972 - $61,311	1,415 Added 0.22%	647,868 $27.4 Million
Q4 2023 Feb 14, 2024	BUY	$32.77 - $42.31 $187,378 - $241,928	5,718 Added 0.89%	646,453 $27 Million
Q3 2023 Nov 14, 2023	SELL	$35.46 - $40.13 $83,153 - $94,104	-2,345 Reduced 0.36%	640,735 $24.2 Million
Q2 2023 Aug 11, 2023	BUY	$24.24 - $40.97 $28,360 - $47,934	1,170 Added 0.18%	643,080 $24.4 Million
Q1 2023 May 15, 2023	SELL	$23.0 - $31.59 $63,342 - $86,998	-2,754 Reduced 0.43%	641,910 $15.6 Million
Q4 2022 Feb 15, 2023	BUY	$27.6 - $32.99 $1.76 Million - $2.11 Million	63,871 Added 11.0%	644,664 $18.7 Million
Q3 2022 Nov 14, 2022	BUY	$28.74 - $39.9 $7,731 - $10,733	269 Added 0.05%	580,793 $17.4 Million
Q2 2022 Aug 16, 2022	BUY	$35.0 - $43.59 $510,055 - $635,237	14,573 Added 2.57%	580,524 $21 Million
Q1 2022 May 17, 2022	BUY	$43.12 - $50.3 $1.16 Million - $1.36 Million	26,984 Added 5.01%	565,951 $24.5 Million
Q4 2021 Feb 15, 2022	SELL	$47.6 - $65.0 $314,921 - $430,040	-6,616 Reduced 1.21%	538,967 $27 Million
Q3 2021 Nov 16, 2021	BUY	$62.34 - $73.38 $117,074 - $137,807	1,878 Added 0.35%	545,583 $34.7 Million
Q2 2021 Aug 13, 2021	SELL	$70.26 - $76.64 $276,402 - $301,501	-3,934 Reduced 0.72%	543,705 $39.1 Million
Q1 2021 May 18, 2021	SELL	$70.48 - $79.95 $423,373 - $480,259	-6,007 Reduced 1.08%	547,639 $40.4 Million
Q4 2020 Feb 17, 2021	BUY	$54.4 - $73.42 $884,979 - $1.19 Million	16,268 Added 3.03%	553,646 $40.6 Million
Q3 2020 Nov 17, 2020	BUY	$54.41 - $68.2 $863,541 - $1.08 Million	15,871 Added 3.04%	537,378 $29.5 Million
Q2 2020 Aug 17, 2020	BUY	$61.66 - $70.16 $2.11 Million - $2.4 Million	34,232 Added 7.03%	521,507 $34.7 Million
Q1 2020 May 18, 2020	BUY	$59.35 - $88.73 $8.75 Million - $13.1 Million	147,456 Added 43.39%	487,275 $29.8 Million
Q4 2019 Feb 18, 2020	BUY	$74.18 - $97.92 $25.2 Million - $33.3 Million	339,819 New	339,819 $29.9 Million

Others Institutions Holding TARO

# of Institutions

Shares Held

17K

Call Options Held

Put Options Held

View Full List

About TARO PHARMACEUTICAL INDUSTRIES LTD

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

More about TARO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Krensavage Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krensavage Asset Management, LLC with notifications on news.

Account